4th Quarter - Report

CAPITOL HILL CONSULTING GROUP for ASTELLAS PHARMA US

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues pertaining to antimicrobial resistance; community and health care associated infections and organ transplantation; STARR Act

Foreign entity interest: Astellas Pharma, Inc., based in Tokyo, Japan, the owner of Astellas Pharma US as identified in its LD-1, has an interest in each issue on which Astellas Pharma US lobbies and would benefit from the specific desired outcome in the matters described above.

LobbyistCovered position, as disclosed
BILL K BREWSTER —
STEVEN E IRIZARRY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Issues related to Medicare coverage of immunosuppressants

Foreign entity interest: Astellas Pharma, Inc., based in Tokyo, Japan, the owner of Astellas Pharma US as identified in its LD-1, has an interest in each issue on which Astellas Pharma US lobbies and would benefit from the specific desired outcome in the matters described above.

LobbyistCovered position, as disclosed
BILL K BREWSTER —
STEVEN E IRIZARRY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.